Simon Rushbrook

6.3k total citations · 1 hit paper
46 papers, 2.2k citations indexed

About

Simon Rushbrook is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Simon Rushbrook has authored 46 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hepatology, 25 papers in Epidemiology and 15 papers in Surgery. Recurrent topics in Simon Rushbrook's work include Liver Disease Diagnosis and Treatment (18 papers), Liver Diseases and Immunity (16 papers) and Hepatitis C virus research (8 papers). Simon Rushbrook is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Liver Diseases and Immunity (16 papers) and Hepatitis C virus research (8 papers). Simon Rushbrook collaborates with scholars based in United Kingdom, Canada and Italy. Simon Rushbrook's co-authors include Nicholas Coleman, Sarah L. Vowler, Lesley S. Morris, Esther Unitt, Aileen Marshall, Graeme Alexander, Graeme Alexander, Nathan Davies, Ian Scott and William Gelson and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Simon Rushbrook

44 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS‐9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis

2019 205 citations Michael Trauner, Aliya Gulamhusein et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simon Rushbrook United Kingdom	24	1.0k	850	627	617	534	46	2.2k
Weici Zhang United States	33	1.4k 1.3×	1.0k 1.2×	392 0.6×	708 1.1×	778 1.5×	78	2.7k
Eli Brazowski Israel	26	500 0.5×	875 1.0×	603 1.0×	590 1.0×	630 1.2×	73	2.4k
Taofic Mounajjed United States	25	703 0.7×	788 0.9×	408 0.7×	762 1.2×	165 0.3×	90	1.9k
David Scholten Germany	16	1.5k 1.5×	1.4k 1.7×	270 0.4×	507 0.8×	444 0.8×	24	2.8k
Kiyoshi Fukunaga Japan	26	712 0.7×	444 0.5×	356 0.6×	691 1.1×	321 0.6×	85	1.9k
Oliver Krenkel Germany	14	1.0k 1.0×	1.3k 1.5×	296 0.5×	367 0.6×	879 1.6×	24	2.7k
Stuart M. Curbishley United Kingdom	21	979 1.0×	799 0.9×	263 0.4×	482 0.8×	847 1.6×	38	2.2k
Evaggelia Liaskou United Kingdom	21	847 0.8×	781 0.9×	257 0.4×	385 0.6×	685 1.3×	31	1.9k
Marta I. Minervini United States	22	640 0.6×	543 0.6×	294 0.5×	616 1.0×	303 0.6×	63	1.7k
Johannes Herkel Germany	32	1.9k 1.9×	1.6k 1.9×	391 0.6×	566 0.9×	1.2k 2.2×	73	3.5k

Countries citing papers authored by Simon Rushbrook

Since Specialization

Citations

This map shows the geographic impact of Simon Rushbrook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Rushbrook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Rushbrook more than expected).

Fields of papers citing papers by Simon Rushbrook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Rushbrook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Rushbrook. The network helps show where Simon Rushbrook may publish in the future.

Co-authorship network of co-authors of Simon Rushbrook

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Rushbrook. A scholar is included among the top collaborators of Simon Rushbrook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Rushbrook. Simon Rushbrook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

High, Juliet, Matthew Hammond, Lee Shepstone, et al.. (2025). Assessing brodalumab in the treatment of primary sclerosing cholangitis (SABR-PSC pilot study): protocol for a single-arm, multicentre, pilot study. BMJ Open Gastroenterology. 12(1). e001596–e001596.

Goode, Elizabeth C., Laura Fachal, Nikolaos Panousis, et al.. (2024). Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci. Nature Communications. 15(1). 9594–9594. 1 indexed citations

Parker, Aimée, James Lazenby, Charlotte Hellmich, et al.. (2024). Regulation of intestinal senescence during cholestatic liver disease modulates barrier function and liver disease progression. JHEP Reports. 6(10). 101159–101159. 5 indexed citations

Rushbrook, Simon, Timothy J. Kendall, Yoh Zen, et al.. (2023). British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma. Gut. 73(1). 16–46. 33 indexed citations

Jones, David, Laura Ogle, George Mells, et al.. (2022). The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study. EBioMedicine. 80. 104068–104068. 8 indexed citations

Fatourou, Evangelia, Dominic King, Martine Walmsley, et al.. (2021). PMO-35 UK national audit on diagnosis and management of colitis in patients with primary sclerosing cholangitis. A94.2–A95. 1 indexed citations

Ogle, Laura, George Mells, Jonathan Badrock, et al.. (2021). The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis. Hepatology. 74(6). 3269–3283. 21 indexed citations

Kowdley, Kris V., Raj Vuppalanchi, Cynthia Levy, et al.. (2020). A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis. Journal of Hepatology. 73(1). 94–101. 142 indexed citations

Trauner, Michael, Aliya Gulamhusein, Bilal Hameed, et al.. (2019). The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC.. Hepatology. 3 indexed citations

10.

Vauzour, David, Ildefonso Rodríguez‐Ramiro, Simon Rushbrook, et al.. (2017). n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(1). 69–78. 28 indexed citations

11.

Goode, Elizabeth C., et al.. (2013). A Rare Cause of Cholangiopathy. Gastroenterology. 144(7). e14–e15. 7 indexed citations

12.

Srivastava, Brijesh, George Mells, Heather J. Cordell, et al.. (2012). Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. 47(7). 820–826. 35 indexed citations

13.

Rushbrook, Simon, et al.. (2008). A rare cause of portal hypertension: Figure 1. Gut. 58(1). 59–59. 1 indexed citations

14.

Rushbrook, Simon, Matthew Hoare, & Graeme Alexander. (2007). T-regulatory lymphocytes and chronic viral hepatitis. Expert Opinion on Biological Therapy. 7(11). 1689–1703. 22 indexed citations

15.

Rushbrook, Simon, Scott M. Ward, Esther Unitt, et al.. (2005). Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8 ⁺ T Cells during Persistent Hepatitis C Virus Infection. Journal of Virology. 79(12). 7852–7859. 233 indexed citations

16.

Scott, Ian, Lesley S. Morris, Simon Rushbrook, et al.. (2005). Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology. Neuropathology and Applied Neurobiology. 31(5). 455–466. 23 indexed citations

17.

Davies, R J, Ian Scott, Laurel Morris, et al.. (2004). Increased expression of minichromosome maintenance protein 2 in active inflammatory bowel disease. Colorectal Disease. 6(2). 103–110. 4 indexed citations

18.

Scott, Ian, Laurel Morris, Simon Rushbrook, et al.. (2004). A novel immunohistochemical method for estimating cell cycle phase distribution in ovarian serous neoplasms: implications for the histopathological assessment of paraffin-embedded specimens. British Journal of Cancer. 90(8). 1583–1590. 42 indexed citations

19.

Scott, Ian, Lesley S. Morris, K Bird, et al.. (2003). A novel immunohistochemical method to estimate cell‐cycle phase distribution in archival tissue: implications for the prediction of outcome in colorectal cancer. The Journal of Pathology. 201(2). 187–197. 77 indexed citations

20.

Freeman, A., Saeed Hamid, Laurel Morris, et al.. (2003). Improved detection of hepatocyte proliferation using antibody to the pre‐replication complex: an association with hepatic fibrosis and viral replication in chronic hepatitis C virus infection. Journal of Viral Hepatitis. 10(5). 345–350. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact